Skip to main content

Dr Melissa Farnham awarded Diabetes Australia grant

14th September, 2020

Dr Melissa Farnham was awarded a Diabetes Australia research grant for her work investigating the protective effects of a ketogenic diet against severe hypoglycaemia that frequently occurs in people with diabetes.

Read more

HRI sheds further light on relationship between diet and cardiometabolic disease

10th September, 2020

Recent HRI research has validated the metabolic pathways that link dietary components with the risk of developing cardiovascular disease.

Read more

Dr Lining (Arnold) Ju – Young Tall Poppy Science Award

24th August, 2020

HRI’s Dr Lining (Arnold) Ju has been recognised for his research excellence and public outreach in the Young Tall Poppy Science Awards for his research into heart disease.

Read more

Dr Mary Kavurma awarded ACvA Research Catalyst Grant

20th August, 2020

Dr Mary Kavurma has been awarded an Australian Cardiovascular Alliance Research Catalyst Grant for her research into peripheral artery disease.

Read more

Dr Ashish Misra awarded Perpetual IMPACT grant

3rd August, 2020

Dr Ashish Misra, leader of the Atherosclerosis and Vascular Remodelling Unit at HRI, has been awarded the Perpetual IMPACT grant.

Read more

Unprecedented drug design minimising side effects

23rd July, 2020

HRI has developed an unprecedented drug design strategy that tailors drugs with fatty acids to minimise side effects.

Read more

Global media interest in HRI’s breakthrough anti-clotting drug for COVID-19

15th June, 2020

The revolutionary new anti-clotting medicine developed by HRI has attracted global media interest due to its far-reaching impact.

Read more

HRI researchers on cusp of worldwide breakthrough in COVID-19 treatment

15th June, 2020

Researchers at HRI believe they may hold the key to controlling the deadly blood clots caused by COVID-19.

Read more

HRI announces novel anti-clotting drug to help critically ill COVID-19 patients

9th June, 2020

HRI is on the precipice of a significant research breakthrough for the treatment of one of the major life-threatening complications of the novel coronavirus (COVID-19), microscopic blood clots.

Read more

Give

Every donation to the Heart Research Institute is an investment into the lives of millions.

Help us to make a long-lasting difference by donating now.

Other ways you can help

HRI breakthrough drug for coronavirus

Read full article